BMP-2 mediates PGE 2-induced reduction of proliferation and osteogenic differentiation of human tendon stem cells

Journal of Orthopaedic Research

Volumn 30, Issue 1, 2012, Pages 47-52

  Zhang, Jianying ^a   Wang, James H C ^a  

^a PA 15260   (United States)

Author keywords

differentiation; osteogenesis; proliferation; tendinopathy; tendon stem cells

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; PROSTAGLANDIN E2;

ARTICLE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; STEM CELL; TENDON;

ADULT; BONE MORPHOGENETIC PROTEIN 2; CALCINOSIS; CELL DIFFERENTIATION; CELL DIVISION; CELLS, CULTURED; DINOPROSTONE; HUMANS; MIDDLE AGED; OSTEOGENESIS; PATELLAR LIGAMENT; STEM CELLS; TENDINOPATHY;

EID: 81555201513     PISSN: 07360266     EISSN: 1554527X     Source Type: Journal    
DOI: 10.1002/jor.21485     Document Type: Article

References (35)

1. Bi Y, Ehirchiou D, Kilts TM, et al. 2007. Identification of tendon stem/progenitor cells and the role of the extracellular matrix in their niche. Nat Med 13: 1219-1227. (Pubitemid 47530625)
2. Zhang J, Pan T, Liu Y, et al. 2010. Mouse treadmill running enhances tendons by expanding the pool of tendon stem cells (TSCs) and TSC-related cellular production of collagen. J Orthop Res 28: 1178-1183.
3. Zhang J, Wang JH,. 2010. Characterization of differential properties of rabbit tendon stem cells and tenocytes. BMC Musculoskelet Disord 11: 10.
4. Zhou Z, Akinbiyi T, Xu L, et al. 2010. Tendon-derived stem/progenitor cell aging: defective self-renewal and altered fate. Aging Cell 9: 911-915.
5. Maffulli N, Khan KM, Puddu G,. 1998. Overuse tendon conditions: time to change a confusing terminology. Arthroscopy 14: 840-843. (Pubitemid 28531671)
6. Cook JL, Purdam CR,. 2009. Is tendon pathology a continuum? A pathology model to explain the clinical presentation of load-induced tendinopathy. Br J Sports Med 43: 409-416.
7. Rees JD, Wilson AM, Wolman RL,. 2006. Current concepts in the management of tendon disorders. Rheumatology (Oxford) 45: 508-521.
8. Khan KM, Cook JL, Bonar F, et al. 1999. Histopathology of common tendinopathies. Update and implications for clinical management. Sports Med 27: 393-408. (Pubitemid 29346822)
9. Kannus P, Jozsa L,. 1991. Histopathological changes preceding spontaneous rupture of a tendon. A controlled study of 891 patients. J Bone Joint Surg Am 73: 1507-1525.
10. Almekinders LC, Banes AJ, Ballenger CA,. 1993. Effects of repetitive motion on human fibroblasts. Med Sci Sports Exerc 25: 603-607. (Pubitemid 23138079)
11. Wang JH, Jia F, Yang G, et al. 2003. Cyclic mechanical stretching of human tendon fibroblasts increases the production of prostaglandin E2 and levels of cyclooxygenase expression: a novel in vitro model study. Connect Tissue Res 44: 128-133. (Pubitemid 37304544)
12. Flick J, Devkota A, Tsuzaki M, et al. 2006. Cyclic loading alters biomechanical properties and secretion of PGE2 and NO from tendon explants. Clin Biomech (Bristol, Avon) 21: 99-106. (Pubitemid 41728098)
13. Zhang J, Wang JH,. 2010. Production of PGE(2) increases in tendons subjected to repetitive mechanical loading and induces differentiation of tendon stem cells into non-tenocytes. J Orthop Res 28: 198-203.
14. Cilli F, Khan M, Fu F, et al. 2004. Prostaglandin E2 affects proliferation and collagen synthesis by human patellar tendon fibroblasts. Clin J Sport Med 14: 232-236. (Pubitemid 38989680)
15. Chen D, Zhao M, Mundy GR,. 2004. Bone morphogenetic proteins. Growth Factors 22: 233-241. (Pubitemid 40136452)
16. Huang W, Carlsen B, Wulur I, et al. 2004. BMP-2 exerts differential effects on differentiation of rabbit bone marrow stromal cells grown in two-dimensional and three-dimensional systems and is required for in vitro bone formation in a PLGA scaffold. Exp Cell Res 299: 325-334. (Pubitemid 39179800)
17. Puchacz E, Lian JB, Stein GS, et al. 1989. Chromosomal localization of the human osteocalcin gene. Endocrinology 124: 2648-2650. (Pubitemid 19132073)
18. Gross S, Tilly P, Hentsch D, et al. 2007. Vascular wall-produced prostaglandin E2 exacerbates arterial thrombosis and atherothrombosis through platelet EP3 receptors. J Exp Med 204: 311-320. (Pubitemid 46294547)
19. Miller SB,. 2006. Prostaglandins in health and disease: an overview. Semin Arthritis Rheum 36: 37-49. (Pubitemid 44128595)
20. Langberg H, Boushel R, Skovgaard D, et al. 2003. Cyclo-oxygenase-2 mediated prostaglandin release regulates blood flow in connective tissue during mechanical loading in humans. J Physiol 551: 683-689. (Pubitemid 37121723)
21. Koshima H, Kondo S, Mishima S, et al. 2007. Expression of interleukin-1beta, cyclooxygenase-2, and prostaglandin E2 in a rotator cuff tear in rabbits. J Orthop Res 25: 92-97. (Pubitemid 46070735)
22. Geiger M, Li RH, Friess W,. 2003. Collagen sponges for bone regeneration with rhBMP-2. Adv Drug Deliv Rev 55: 1613-1629. (Pubitemid 37420006)
23. Gautschi OP, Cadosch D, Zellweger R, et al. 2009. Apoptosis induction and reduced proliferation in human osteoblasts by rhBMP-2, -4 and -7. J Musculoskelet Neuronal Interact 9: 53-60.
24. Alvarez-Rodriguez R, Barzi M, Berenguer J, et al. 2007. Bone morphogenetic protein 2 opposes Shh-mediated proliferation in cerebellar granule cells through a TIEG-1-based regulation of Nmyc. J Biol Chem 282: 37170-37180.
25. Lui PP, Chan LS, Cheuk YC, et al. 2009. Expression of bone morphogenetic protein-2 in the chondrogenic and ossifying sites of calcific tendinopathy and traumatic tendon injury rat models. J Orthop Surg Res 4: 27.
26. Rui YF, Lui PP, Ni M, et al. 2011. Mechanical loading increased BMP-2 expression which promoted osteogenic differentiation of tendon-derived stem cells. J Orthop Res 29: 390-396.
27. Li Z, Yang G, Khan M, et al. 2004. Inflammatory response of human tendon fibroblasts to cyclic mechanical stretching. Am J Sports Med 32: 435-440. (Pubitemid 38235513)
28. Meyer-Siegler K,. 2001. COX-2 specific inhibitor, NS-398, increases macrophage migration inhibitory factor expression and induces neuroendocrine differentiation in C4-2b prostate cancer cells. Mol Med 7: 850-860. (Pubitemid 34175308)
29. Arikawa T, Omura K, Morita I,. 2004. Regulation of bone morphogenetic protein-2 expression by endogenous prostaglandin E2 in human mesenchymal stem cells. J Cell Physiol 200: 400-406. (Pubitemid 39006932)
30. Kleiveland CR, Kassem M, Lea T,. 2008. Human mesenchymal stem cell proliferation is regulated by PGE2 through differential activation of cAMP-dependent protein kinase isoforms. Exp Cell Res 314: 1831-1838.
31. Scutt A, Bertram P,. 1995. Bone marrow cells are targets for the anabolic actions of prostaglandin E2 on bone: induction of a transition from nonadherent to adherent osteoblast precursors. J Bone Miner Res 10: 474-487.
32. Langberg H, Skovgaard D, Karamouzis M, et al. 1999. Metabolism and inflammatory mediators in the peritendinous space measured by microdialysis during intermittent isometric exercise in humans. J Physiol 515 (Pt 3): 919-927. (Pubitemid 29140124)
33. Thampatty BP, Im HJ, Wang JH,. 2006. Leukotriene B4 at low dosage negates the catabolic effect of prostaglandin E2 in human patellar tendon fibroblasts. Gene 372: 103-109. (Pubitemid 44316795)
34. Yee Lui PP, Wong YM, Rui YF, et al. 2011. Expression of chondro-osteogenic BMPs in ossified failed tendon healing model of tendinopathy. J Orthop Res 29: 816-821.
35. Noth U, Tuli R, Seghatoleslami R, et al. 2003. Activation of p38 and Smads mediates BMP-2 effects on human trabecular bone-derived osteoblasts. Exp Cell Res 291: 201-211. (Pubitemid 37338693)